31.03.2023 | Webinars
For anyone in a pharmaceutical company who is new to the concept of a Digital Opinion Leader
By Mary Fletcher-Louis and Mary Kangley
07.03.2023 | Article
CREATION.co celebrates 5 female Digital Opinion Leaders Oncologists.
By Mary Kangley
11.01.2023 | Article
2023 will see almost 90% of the events within the pharma industry being held in person
By Natalie Verghese
05.08.2022 | Article
Learn about 14 ways pharma can engage HCP Digital Opinion Leaders - CREATION.co has 10+ year
By Katie Kennedy
09.09.2022 | Whitepaper
The way HCPs utilise social media channels to engage and collaborate is changing...
26.05.2023 | Article
Exploring the online HCP conversation surrounding ulcerative colitis
By Jamie Doggett
21.05.2023 | Article
Bringing you the latest insights into online HCPs' respiratory disease related conversation
By Emily Fletcher-Louis
19.05.2023 | Webinars
How can pharma support HCPs in tackling medical misinformation online?
By Jamie Doggett and Francesca Gan
19.05.2023 | Webinars
For anyone in the pharma industry who would like to understand the behaviour of HCPs online
By Mary Fletcher-Louis and Mary Kangley
19.05.2023 | Article
CREATION.co studied the conversation of eHCPs around rare disease in the last 12 months
By Emily Fletcher-Louis
03.05.2023 | Article
Exploring the online eHCP conversation surrounding dapagliflozin
By Jamie Doggett
02.05.2023 | Article
Reflections on our time at Reuters Pharma Europe 2023
By Mary Fletcher-Louis
02.05.2023 | Article
CREATION Pinpoint tracked what over 4,500 eHCPs had to say on paediatric obesity
By Mark Sullivan
01.05.2023 | Article
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Imma Tinat
01.05.2023 | Article
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
23.04.2023 | Article
Bringing you the latest insights into online HCPs' respiratory disease related conversation
By Emily Fletcher-Louis and Hannah Ghinn
01.04.2023 | Article
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Imma Tinat